Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

about

Emerging treatment options for BRAF-mutant colorectal cancer.Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers

P2860

Q52599786-11026989-3287-4268-B7F6-596973754847 Q57071817-955462DB-0B60-4FC5-9E98-55F7B080D5BC

P2860

Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

Item

http://www.wikidata.org/entity/Q40428222

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Differential Radiographic Appe ...... hed by Primary Tumor Location.

@en

type

Item

label

Differential Radiographic Appe ...... hed by Primary Tumor Location.

@en

prefLabel

Differential Radiographic Appe ...... hed by Primary Tumor Location.

@en

P1476

Differential Radiographic Appe ...... hed by Primary Tumor Location.

@en

P2093

Alan P Venook

http://www.w3.org/2001/XMLSchema#string

Benjamin M Yeh

http://www.w3.org/2001/XMLSchema#string

Chloe E Atreya

http://www.w3.org/2001/XMLSchema#string

Claire Greene

http://www.w3.org/2001/XMLSchema#string

I Elaine Allen

http://www.w3.org/2001/XMLSchema#string

Katherine Van Loon

http://www.w3.org/2001/XMLSchema#string

Nabia S Ikram

http://www.w3.org/2001/XMLSchema#string

Ryan M McWhirter

http://www.w3.org/2001/XMLSchema#string

Spencer C Behr

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Comprehensive molecular characterization of human colon and rectal cancer

Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Mutations of the BRAF gene in human cancer

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.

P304

1536-1543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2016.0165

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27956538

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5551390

http://www.w3.org/2001/XMLSchema#string

Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

about

P2860

P2860

Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932